Chen, I.-H.; Hsu, C.-C.; Yong, C.-C.; Cheng, Y.-F.; Wang, C.-C.; Lin, C.-C.; Chen, C.-L.
AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation. Cancers 2023, 15, 1551.
https://doi.org/10.3390/cancers15051551
AMA Style
Chen I-H, Hsu C-C, Yong C-C, Cheng Y-F, Wang C-C, Lin C-C, Chen C-L.
AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation. Cancers. 2023; 15(5):1551.
https://doi.org/10.3390/cancers15051551
Chicago/Turabian Style
Chen, I-Hsuan, Chien-Chin Hsu, Chee-Chien Yong, Yu-Fan Cheng, Chih-Chi Wang, Chih-Che Lin, and Chao-Long Chen.
2023. "AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation" Cancers 15, no. 5: 1551.
https://doi.org/10.3390/cancers15051551
APA Style
Chen, I.-H., Hsu, C.-C., Yong, C.-C., Cheng, Y.-F., Wang, C.-C., Lin, C.-C., & Chen, C.-L.
(2023). AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation. Cancers, 15(5), 1551.
https://doi.org/10.3390/cancers15051551
